Solvonis Therapeutics plc (LON: SVNS)
London
· Delayed Price · Currency is GBP · Price in GBX 0.185
+0.002 (1.09%)
Jan 31, 2025, 8:00 AM BST
Solvonis Therapeutics Revenue
Solvonis Therapeutics had revenue of 347.00K GBP in the twelve months ending June 30, 2024, down -23.06% year-over-year. In the year 2023, Solvonis Therapeutics had annual revenue of 587.00K with 8.30% growth.
Revenue (ttm)
347.00K
Revenue Growth
-23.06%
P/S Ratio
0.61
Revenue / Employee
49.57K
Employees
7
Market Cap
4.25M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| Shell | 227.10B |
| HSBC Holdings | 43.25B |
| Unilever | 51.12B |
| Rio Tinto Group | 42.87B |
| RELX PLC | 9.30B |
| British American Tobacco p.l.c. | 26.18B |
| BP p.l.c. | 144.69B |